Boston Scientific has led a $23.1m series B round for Neurotronik, a medical device devloper focusing on patients suffering from heart failure.
Ireland-based medical device developer Neurotronik has closed a $23.1m series B round led by medical equipment producer Boston Scientific, with the funding to be provided in tranches in line with milestones.
The round was supported by Hatteras Venture Partners, Synergy Life Science Partners, Lord Baltimore Investment Partners, Mountain Group Capital and Sovereign’s Capital as well as undisclosed financial and industry participants.
Founded in 2012, Neurotronik has developed neurostimulation therapy to stimulate a patient’s cardiac function. The technology aims to improve…